A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris
- PMID: 30388
A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris
Abstract
Three beta1-selective beta-blocker (metoprolol, practolol and H 87/07) were compared in 29 patients with stable angina pectoris. The main pharmacological difference between the three beta-blockers was their intrinsic stimulating activity (I.S.A.), metoprolol being devoid of I.S.A., practolol having moderate I.S.A. and H 87/07 having high I.S.A. Each drug was given in randomized order and the length of each cross-over period was 2 weeks. Daily activity was measured by an automatic step-counter, and subjective symptoms and nitroglycerin consumption were registered on a diary-card. Objective data, such as ECG changes and exercise capacity, were obtained by bicycle ergometer tests performed at the end of each period. At rest, the heart rate was significantly lower on metoprolol than on practolol or H 87/07. During exercise, the heart rate was significantly higher on H 87/07 than on practolol or metoprolol. No other haemodynamic differences were found between the three beta-blockers. No differences were found between the three test periods with regard to daily activity, expressed as the number of steps walked, while on the beta-blocker with high I.S.A., H 87/07, the attack rate and nitroglycerin consumption were significantly higher than when the patients were on metoprolol and practolol. No difference was found between the three beta-blockers with regard to total work or exercise time until 1 mm of S-T segment depression. Except for one patient who experienced a severe exanthema on practolol, the three beta-blockers were equally well tolerated.
Similar articles
-
Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.Ann Clin Res. 1975 Dec;7(6):433-41. Ann Clin Res. 1975. PMID: 2092 Clinical Trial.
-
Effects of a new beta1-selective beta-blocker H 87/07 in angina pectoris.Ann Clin Res. 1977 Oct;9(5):305-10. Ann Clin Res. 1977. PMID: 28687 Clinical Trial.
-
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.N Engl J Med. 1979 Apr 5;300(14):750-5. doi: 10.1056/NEJM197904053001402. N Engl J Med. 1979. PMID: 581782 Clinical Trial.
-
Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.J Cardiovasc Pharmacol. 1990;16 Suppl 5:S123-8. J Cardiovasc Pharmacol. 1990. PMID: 11527115 Review.
-
Beta-adrenergic receptor blocking drugs in angina pectoris.Drugs. 1974;7(1):55-84. doi: 10.2165/00003495-197407010-00005. Drugs. 1974. PMID: 4151695 Review. No abstract available.